- Home
- ALTG vs CRDF Comparison
ALTG vs CRDF Comparison
Compare ALTG & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- CRDF
- Stock Information
- Founded
- ALTG 1984
- CRDF 1999
- Country
- ALTG United States
- CRDF United States
- Employees
- ALTG N/A
- CRDF N/A
- Industry
- ALTG Industrial Machinery/Components
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALTG Industrials
- CRDF Health Care
- Exchange
- ALTG Nasdaq
- CRDF Nasdaq
- Market Cap
- ALTG 247.6M
- CRDF 144.4M
- IPO Year
- ALTG N/A
- CRDF N/A
- Fundamental
- Price
- ALTG $8.56
- CRDF $2.17
- Analyst Decision
- ALTG Hold
- CRDF Strong Buy
- Analyst Count
- ALTG 3
- CRDF 5
- Target Price
- ALTG $11.67
- CRDF $11.10
- AVG Volume (30 Days)
- ALTG 254.6K
- CRDF 1.2M
- Earning Date
- ALTG 08-07-2025
- CRDF 11-06-2025
- Dividend Yield
- ALTG 2.66%
- CRDF N/A
- EPS Growth
- ALTG N/A
- CRDF N/A
- EPS
- ALTG N/A
- CRDF N/A
- Revenue
- ALTG $1,851,100,000.00
- CRDF $545,000.00
- Revenue This Year
- ALTG $1.30
- CRDF N/A
- Revenue Next Year
- ALTG $3.26
- CRDF N/A
- P/E Ratio
- ALTG N/A
- CRDF N/A
- Revenue Growth
- ALTG N/A
- CRDF N/A
- 52 Week Low
- ALTG $3.54
- CRDF $1.90
- 52 Week High
- ALTG $8.99
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- ALTG 59.82
- CRDF 38.40
- Support Level
- ALTG $7.99
- CRDF $1.90
- Resistance Level
- ALTG $8.88
- CRDF $2.39
- Average True Range (ATR)
- ALTG 0.36
- CRDF 0.13
- MACD
- ALTG 0.02
- CRDF 0.03
- Stochastic Oscillator
- ALTG 79.94
- CRDF 40.91
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.